Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

#174; Extra Strength Caplets 100CT

300672000910

10300672000917

0067200091

 100007201

Excedrin® Extra Strength Caplets 125CT Bonus Pack

300672000835

10300672000832

0067200083

 100008434

Excedrin® Extra Strength Caplets 125CT Bonus Pack Account Specific

300672000842

10300672000849

0067200084

 100008455

Excedrin® Extra Strength Caplets 125CT New Carton

300672000866

10300672000863

0067200086

 100009008

Excedrin® Extra Strength  Caplets 24+6CT Bonus Pack

300672000309

10300672000306

0067200030

 100003157

Excedrin® Extra Strength  Caplets 24CT

300672000248

10300672000245

0067200024

 100008024

Excedrin® Extra Strength  Caplets 24CT New Label

300672000248

10300672000245

0067200024

 100004485

Excedrin® Extra Strength  Caplets 250CT No Carton

300672000071

10300672000078

0067200007

 100008033

Excedrin® Extra Strength  Caplets 250CT No Carton New Label

300672000071

10300672000078

0067200007

 100004868

Excedrin® Extra Strength  Caplets 250CT Special Inner

300672000774

10300672000771

0067200077

 100008029

Excedrin® Extra Strength  Caplets 250CT New Label

300672000774

10300672000771

0067200077

 100008635

Excedrin® Extra Strength  Caplets 300CT Bonus Pack

300672000552

10300672000559

0067200055

 100008025

Excedrin® Extra Strength  Caplets 50CT New Label
'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015 Vermillion, Inc. (Nasdaq: ... focused on gynecologic disease, announced today it will ... the market open on Wednesday, March 25, 2015, ... at 8:30am Eastern. Conference Call & Webcast: ... Eastern/5:30am Pacific Domestic: , 800-753-9057International: , 913-981-5571Conference ID: ...
(Date:3/5/2015)... 5, 2015  BioPhotas, Inc., an FDA registered medical ... photo-therapeutic technologies to treat skin, muscle and joint conditions, ... Fi Fund to provide BioPhotas, flagship product, the ... management solutions.  Commenting on the alliance, ... used the Celluma at the Warrior Hope and Care ...
(Date:3/5/2015)... 5, 2015  Medical Diagnostic Laboratories, L.L.C., (MDL), ... complexity, state-of-the-art, automated DNA-based molecular analyses, announces that ... testing which utilizes cutting edge technology, including next- ... approximately 12,000 women are diagnosed with cervical cancer ... Genital Human Papillomaviruses (HPV) are a group of ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... 2011 As the biopharmaceutical marketplace has evolved, leading ... to change as well. Specifically, Market Research is shifting ... shaping strategic objectives for key commercial groups. ... increasingly use new and innovative tools such as Webcams ...
... 10, 2011 American Medical Systems® (AMS) (Nasdaq: ... and therapies for male and female pelvic health, today ... of the Elevate® Anterior and Apical Prolapse Repair System. ... quantify, describe and stage pelvic support, was implemented in ...
Cached Medicine Technology:Strategic Role Becoming Critical Part of Market Research Function 2Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS' Elevate Anterior and Apical Prolapse Repair System 2
(Date:3/5/2015)... AZ (PRWEB) March 05, 2015 The ... various kinds of income to the Arizona economy each ... The report, Demonstrating the Economic Value of Maricopa County ... investment of the Maricopa district in fiscal year 2013-2014. ... Modeling Specialists International (EMSI), an organization that specializes ...
(Date:3/5/2015)... MS (PRWEB) March 05, 2015 At ... Basics and Beyond,” leaders in addiction treatment met today ... updates in best clinical practices. Among the numerous respected ... , who will address the role that pain medications ... and new evidence-based treatment options. , "It is hard ...
(Date:3/5/2015)... March 05, 2015 Taking center ... Fort Worth, Texas April 9-11th is IDRevolution hosted ... providing personalized nutrition. IDLife offers a variety ... This customized approach to vitamin supplementation is ... with a free HIPAA compliant online assessment and ...
(Date:3/5/2015)... Harrisburg, NC (PRWEB) March 05, 2015 ... of Physician Assistants’ (AAPA) review of Clearstream, ... AAPA determined that Clearstream’s MediDefense line of products—led ... of the AAPA’s Affinity Partner Program. , The ... physician assistants across all medical and surgical specialties ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Jordan Valley ... LifeVest® as a treatment option for sudden cardiac arrest. ... heart rhythm and can detect any life-threatening abnormalities. If ... alert the patient before delivering a treatment shock to ... Adam Elhaddi of Jordan Valley Medical Center and the ...
Breaking Medicine News(10 mins):Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 2Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 3Health News:Clearstream’s Line of MediDefense Antimicrobial Products Scores Affinity Partnership With American Academy of Physician Assistants (AAPA) 4Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3
... 8, 2011 Children who suffer from persistent or recurring ... are at risk of developing internalizing symptoms such as anxiety, ... review of chronic pain in children and adolescents in 20 ... are suffering from chronic pain and that girls suffer more ...
... , THURSDAY, Dec. 8 (HealthDay News) -- Breast cancer ... have a 10 percent greater risk for developing cancer in ... woman receives her first diagnosis before age 40, new research ... [with this mutation] who have already had cancers are also ...
... Los Angeles, CA (DECEMBER 8, 2011) Young football players may ... study released in Journal of Child Neurology (JCN), ... and Dr. Meredith R. Golomb looked at various case studies ... and found some potential causes for strokes in young football ...
... THURSDAY, Dec. 8 (HealthDay News) -- Rats may have ... scroungers, a new study found that the rodents showed ... companions, even when they,re given the opportunity to eat ... in rodents suggests that this type of pro-social helping ...
... that combines an adjusted blood test with other factors including ... family history, can help up to one-quarter of men avoid ... Deaconess Medical Center-led research team says. Writing in a ... team led by Martin G. Sanda, MD, Director of the ...
... Lunenfeld Research Institute,s Drs. Frank Sicheri, Tony Pawson and ... the Ontario Cancer Institute, have uncovered the detailed architecture ... to the bone development disorder cherubism and involved in ... first structural insight into precisely how the enzyme correctly ...
Cached Medicine News:Health News:Chronic pain in children and adolescents becoming more common 2Health News:Breast Cancer Gene Puts Survivors at Higher Odds for Recurrence 2Health News:Rats Can Lend a Helping Paw to Others, Study Finds 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 3Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 2Health News:Toronto researchers obtain detailed molecular 'signature' for Tankyrase 3
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Maumenee vitreous aspirating cannula, 18 gauge....
Reusable blunt cannula with luer hub. Cannula length is 32 mm....
Medicine Products: